Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07414810 · ClinicalTrials.gov registry record · NA
Novel Point-of-care Sweat Chloride Testing Device for Monitoring CFTR Function
A NA study, sponsored by Emory University.
- Not yet
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT07414810: Clinical Trial NA study, sponsored by Emory University.
NCT07414810 is a NA study that has not yet begun recruiting, run by Emory University. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07414810, a NA study, has not yet begun recruiting, sponsored by Emory University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
This study is being done to test a device called micro Sweat Test Patch (mSTP or µSTP). The study team will compare the standard of care (SOC) method of sweat testing with a novel sweat test technique using an integrated micro Sweat Test Patch (µSTP) with microneedle assembly made out of Pilocarpine nitrate, microfluidic channels, and a chloride sensor for point-of-care (POC) measurements of sweat chloride concentrations in newborns being evaluated for cystic fibrosis (CF) diagnosis and in pediatric and adult people with CF (pwCF). The procedures involve performing a SOC sweat test (if they are not a neonate) and the novel sweat test developed by the research team. Recruitment for the study will take place at Children's Healthcare of Atlanta and Emory Healthcare cystic fibrosis clinics.
Primary Outcome
Sweat chloride concentration by the µSTP will be assessed and measured using the sweat test sensor.
Interventions
- DEVICE micro Sweat Test Patch (mSTP)
- DIAGNOSTIC_TEST Sweat Testing using SOC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2026-08 |
| Est. Completion | 2027-07 |
| Phase | NA |
What is known before NCT07414810 opens enrollment
NCT07414810 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 2 interventions - of which micro Sweat Test Patch (mSTP) is the first listed.
NCT07414810 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07414810 about?
NCT07414810 is a clinical study titled "Novel Point-of-care Sweat Chloride Testing Device for Monitoring CFTR Function". This study is being done to test a device called micro Sweat Test Patch (mSTP or µSTP). The study team will compare the standard of care (SOC) method of sweat testing with a novel sweat test technique using an integrated micro Sweat Test Patch (µSTP) with microneedle assembly made out of Pilocarpin...
What is the current status of trial NCT07414810?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2026-08. Estimated completion is 2027-07.
What interventions are being tested in trial NCT07414810?
The interventions under investigation include: micro Sweat Test Patch (mSTP) (DEVICE), Sweat Testing using SOC (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07414810?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07414810's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia